Complete hydatidiform mole with coexisting fetus: A case report

IF 0.6 Q4 OBSTETRICS & GYNECOLOGY
Case Reports in Women's Health Pub Date : 2026-03-01 Epub Date: 2025-11-29 DOI:10.1016/j.crwh.2025.e00770
Yuanhua Xiang, Wei Zhang, Dongmin Chen, Ting Luo
{"title":"Complete hydatidiform mole with coexisting fetus: A case report","authors":"Yuanhua Xiang,&nbsp;Wei Zhang,&nbsp;Dongmin Chen,&nbsp;Ting Luo","doi":"10.1016/j.crwh.2025.e00770","DOIUrl":null,"url":null,"abstract":"<div><div>Complete hydatidiform mole with coexisting fetus (CHMCF) is an exceptionally rare and clinically challenging obstetric condition. Its diagnosis and management require a high index of suspicion and a multidisciplinary approach. This report presents the case of a woman in her 30s who presented for a routine prenatal examination at 15 weeks of gestation. Ultrasonography revealed a placenta with a mixed echogenicity area exhibiting a characteristic honeycomb-like appearance, alongside a coexisting viable fetus with normal biometry. Serum β-human chorionic gonadotropin (β-hCG) was markedly elevated at 259,762 mIU/mL. Through serial monitoring and multidisciplinary consultation, a diagnosis of CHMCF was suspected and later confirmed by postnatal genetic analysis. The pregnancy was complicated by persistent vaginal bleeding at 21 weeks, leading to termination following a comprehensive risk-benefit assessment. This case underscores the diagnostic challenges, the critical role of cytogenetic analysis, the importance of patient counseling regarding the significantly elevated risks of obstetric complications and gestational trophoblastic neoplasia (GTN), and the necessity for meticulous post-evacuation surveillance. This report aims to enhance clinical awareness and outline a structured management protocol for this rare entity.</div></div>","PeriodicalId":9657,"journal":{"name":"Case Reports in Women's Health","volume":"49 ","pages":"Article e00770"},"PeriodicalIF":0.6000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Women's Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214911225000918","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Complete hydatidiform mole with coexisting fetus (CHMCF) is an exceptionally rare and clinically challenging obstetric condition. Its diagnosis and management require a high index of suspicion and a multidisciplinary approach. This report presents the case of a woman in her 30s who presented for a routine prenatal examination at 15 weeks of gestation. Ultrasonography revealed a placenta with a mixed echogenicity area exhibiting a characteristic honeycomb-like appearance, alongside a coexisting viable fetus with normal biometry. Serum β-human chorionic gonadotropin (β-hCG) was markedly elevated at 259,762 mIU/mL. Through serial monitoring and multidisciplinary consultation, a diagnosis of CHMCF was suspected and later confirmed by postnatal genetic analysis. The pregnancy was complicated by persistent vaginal bleeding at 21 weeks, leading to termination following a comprehensive risk-benefit assessment. This case underscores the diagnostic challenges, the critical role of cytogenetic analysis, the importance of patient counseling regarding the significantly elevated risks of obstetric complications and gestational trophoblastic neoplasia (GTN), and the necessity for meticulous post-evacuation surveillance. This report aims to enhance clinical awareness and outline a structured management protocol for this rare entity.
完全性葡萄胎伴胎儿1例
完全葡萄胎合并胎儿(CHMCF)是一种非常罕见且具有临床挑战性的产科疾病。它的诊断和管理需要高度的怀疑和多学科的方法。本报告介绍了一个30多岁的妇女在妊娠15周时进行常规产前检查的病例。超声检查显示胎盘具有混合回声区,表现出典型的蜂窝状外观,同时存在正常生物特征的可存活胎儿。血清β-人绒毛膜促性腺激素(β-hCG)显著升高至259,762 mIU/mL。通过连续监测和多学科会诊,怀疑诊断为CHMCF,后来通过出生后遗传分析证实。妊娠21周时因持续阴道出血而复杂化,在综合风险-收益评估后终止妊娠。该病例强调了诊断的挑战,细胞遗传学分析的关键作用,关于产科并发症和妊娠滋养细胞瘤(GTN)风险显著升高的患者咨询的重要性,以及对撤离后进行细致监测的必要性。本报告旨在提高临床意识,并概述了这种罕见实体的结构化管理方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Women's Health
Case Reports in Women's Health Medicine-Obstetrics and Gynecology
CiteScore
2.10
自引率
0.00%
发文量
89
审稿时长
7 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书